Bifidobacterium

A genus of Gram-positive, obligate anaerobic bacteria that dominate the infant gut microbiome and remain important commensals throughout life. Bifidobacterium species are distinctive in the metallomics context because some species possess Ni-dependent urease — an unusual feature for a commensal genus — while the genus as a whole functions as a key probiotic with metal-binding and detoxification properties.

Nickel-Dependent Urease in Select Species

  • Some Bifidobacterium species carry urease genes and produce active Ni-dependent urease [1].
  • In the commensal context, urease likely serves for nitrogen acquisition (urea is abundant in the gut lumen at ~2-6 mM) rather than as a virulence factor.
  • This commensal urease activity has implications for nickel restriction strategies: dietary nickel limitation aimed at pathogen urease could also affect beneficial Bifidobacterium urease, potentially causing unintended dysbiosis [1].
  • This dual-use problem — pathogen vs. commensal urease — is a key challenge for anti-nickel therapeutic approaches.

Metal Binding and Detoxification

  • Bifidobacterium species demonstrate metal-binding capacity at the cell surface, contributing to heavy metal sequestration in the gut lumen [2].
  • Cell wall peptidoglycan and exopolysaccharides provide carboxyl and phosphoryl groups that chelate divalent metal cations.
  • B. longum, B. breve, and B. lactis have been studied for cadmium, lead, and mercury binding capacity [3].
  • Combined with lactobacillus, Bifidobacterium forms the core of traditional probiotic metal detoxification strategies.

Infant Gut Colonization

  • Bifidobacterium (especially B. infantis, B. breve, B. longum) is the dominant genus in breastfed infant guts, comprising up to 90% of the microbiota [4].
  • Human milk oligosaccharides (HMOs) selectively feed Bifidobacterium, establishing early colonization dominance [5] [6].
  • This dominance creates an acid-producing, nickel-independent microbial environment that naturally suppresses Ni-enzyme-dependent pathogens [7].
  • Formula-fed infants have lower Bifidobacterium and higher Proteobacteriaceae — a shift compounded by formula's higher nickel content [4].
  • The convergence of reduced Bifidobacterium, increased dietary nickel, and enrichment of Ni-urease pathogens in formula-fed preterm infants may explain NEC susceptibility [7].
  • Probiotic supplementation with Bifidobacterium (often combined with Lactobacillus) reduces NEC incidence in very low birth weight preterm infants [8].

Depletion Across Disease States

  • IBD: reduced in both Crohn's disease and ulcerative colitis.
  • Obesity and metabolic syndrome: inversely correlated with BMI; depleted in metabolic dysfunction [9] [10].
  • Type 1 diabetes: depleted in children progressing to T1D [11] [12].
  • Autism spectrum disorder: multiple studies report altered Bifidobacterium in ASD [13].
  • Long COVID: depleted in the gut microbiome of Long COVID patients; Mendelian randomization supports a causal relationship [14] [15].
  • Necrotizing enterocolitis: depleted in preterm infants who develop NEC, alongside reduced SCFA producers [16] [17].
  • Allergic disease: early-life Bifidobacterium depletion associated with increased allergy risk.
  • Iron supplementation effects: excess iron in infant formula may suppress Bifidobacterium while promoting Enterobacteriaceae [18].

SCFA Production and Immune Modulation

  • Produces acetate and lactate via the "bifid shunt" (fructose-6-phosphate phosphoketolase pathway).
  • Acetate production strengthens gut barrier integrity and provides substrate for butyrate production by cross-feeding partners like faecalibacterium prausnitzii [3].
  • Promotes regulatory T cell development and anti-inflammatory IL-10 production.
  • Competes with pathogens for ecological niches without requiring nickel-dependent virulence factors [2].

Connections

  • urease — Ni-urease in some species; complicates anti-nickel strategies
  • nickel — some species Ni-dependent via urease; the commensal collateral damage concern
  • gut metal microbiome — metal-binding probiotic and metal-sensitive commensal
  • iron — suppressed by excess iron supplementation
  • lactobacillus — complementary probiotic genus; co-depleted in disease
  • faecalibacterium prausnitzii — metabolic cross-feeding via acetate-butyrate axis
  • akkermansia muciniphila — co-protective commensal; both depleted in disease
  • nutritional immunity — the commensal-pathogen urease dilemma
  • dysbiosis — depletion is a consistent disease-associated signature
  • inflammation — anti-inflammatory via SCFA production and Treg promotion

References (18)

  1. . maier 2019 nickel microbial pathogenesis
  2. . duan 2020 gut microbiota heavy metal probiotic strategy
  3. . anchidin norocel 2025 heavy metal gut probiotics biosensors
  4. . torrazza 2013 intestinal microbial ecology nec
  5. . sami 2023 human milk nutrients preventing nec
  6. . chapman 2026 clostridia hmos pathobiont suppression nec
  7. . pendergrass 2026 nickel nec preterm gut
  8. . zhou 2023 probiotics prevent nec vlbw meta
  9. . pendergrass 2026 heavy metals obesity epidemic
  10. . ismail 2022 gut microbiome obesity t1d review
  11. . belteky 2023 infant gut microbiome t1d abis study
  12. . de goffau 2014 aberrant gut microbiota onset t1d children
  13. . zhang 2022 probiotics asd rct protocol
  14. . li 2024 causal role gut microbiota long covid mendelian randomization
  15. . rego 2024 impact gut microbiota long covid insights challenges
  16. . liu 2022 nec scfa gut microbiota biomarkers pilot
  17. . lin 2025 nec serum metabolomics fecal microbiome
  18. . bao 2024 iron homeostasis intestinal immunity gut microbiota